nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Bridging gaps in surgical care for neuroendocrine tumours: CUTNETs begins
|
Hallet, Julie |
|
|
10 |
2 |
p. 111 |
artikel |
2 |
Denifanstat for the treatment of metabolic dysfunction-associated steatohepatitis
|
Gao, Ziwei |
|
|
10 |
2 |
p. 108 |
artikel |
3 |
Denifanstat for the treatment of metabolic dysfunction-associated steatohepatitis
|
Li, Xincheng |
|
|
10 |
2 |
p. 108-109 |
artikel |
4 |
Denifanstat for the treatment of metabolic dysfunction-associated steatohepatitis – Authors' reply
|
Kemble, George |
|
|
10 |
2 |
p. 109-110 |
artikel |
5 |
Does filgotinib work for Crohn's disease?
|
Ainsworth, Mark Andrew |
|
|
10 |
2 |
p. 99-100 |
artikel |
6 |
Efficacy and safety of filgotinib as induction and maintenance therapy for Crohn's disease (DIVERSITY): a phase 3, double-blind, randomised, placebo-controlled trial
|
Vermeire, Séverine |
|
|
10 |
2 |
p. 138-153 |
artikel |
7 |
Elimination of hepatitis B requires recognition of catastrophic costs for patients and their families
|
Jemutai, Julie |
|
|
10 |
2 |
p. 100-103 |
artikel |
8 |
Hypovolaemic phlebotomy in patients undergoing hepatic resection at higher risk of blood loss (PRICE-2): a randomised controlled trial
|
Martel, Guillaume |
|
|
10 |
2 |
p. 114-124 |
artikel |
9 |
Hypovolaemic phlebotomy to reduce the need for perioperative transfusion: a price worth paying?
|
Schnitzbauer, Andreas A |
|
|
10 |
2 |
p. 96-97 |
artikel |
10 |
Implementing metabolic dysfunction-associated steatotic liver disease guidelines in patients with type 2 diabetes
|
Ciardullo, Stefano |
|
|
10 |
2 |
p. 97-98 |
artikel |
11 |
International consensus statement on microbiome testing in clinical practice
|
Porcari, Serena |
|
|
10 |
2 |
p. 154-167 |
artikel |
12 |
Primary intestinal lymphangiectasia
|
Ross, Rahael |
|
|
10 |
2 |
p. 113 |
artikel |
13 |
Ramadan intermittent fasting for patients with gastrointestinal and hepatobiliary diseases: practical guidance for health-care professionals
|
Usman, Muhammad |
|
|
10 |
2 |
p. 168-182 |
artikel |
14 |
Research in Brief
|
Baker, Holly |
|
|
10 |
2 |
p. 112 |
artikel |
15 |
Screening for advanced liver fibrosis due to metabolic dysfunction-associated steatotic liver disease alongside retina scanning in people with type 2 diabetes: a cross-sectional study
|
Lindfors, Andrea |
|
|
10 |
2 |
p. 125-137 |
artikel |
16 |
Targeting socioeconomic inequity to reduce liver disease related to alcohol use
|
Probst, Charlotte |
|
|
10 |
2 |
p. 103-105 |
artikel |
17 |
The rise in early-onset colorectal cancer: now a global issue
|
The Lancet Gastroenterology & Hepatology, |
|
|
10 |
2 |
p. 95 |
artikel |
18 |
The urgent need to end hepatitis B stigma and discrimination
|
Freeland, Catherine |
|
|
10 |
2 |
p. 105-107 |
artikel |
19 |
Widening access to recombinant zoster vaccination in IBD
|
Alexander, James L |
|
|
10 |
2 |
p. 110-111 |
artikel |